Editorial Research Support, N.I.H., Extramural Ppublish 3 citations
PubMed: 34490838 DOI: 10.1080/17474086.2021.1977117
Strategies to improve pharmacogenomic-guided treatment options for patients with β-hemoglobinopathies.
Expert Rev Hematol 14(10):883-885
Authors: George P Patrinos, David H K Chui, Ross C Hardison, Martin H Steinberg
Affiliations
- School of Health Sciences, Department of Pharmacy, Laboratory of Pharmacogenomics and Individualized Therapy, University of Patras, Patras, Greece.
- College of Medicine and Health Sciences, Department of Pathology, United Arab Emirates University, Al-Ain, UAE.
- Zayed Center of Health Sciences, United Arab Emirates University, Al-Ain, UAE.
- Departments of Medicine, Pathology and Laboratory Medicine, Boston University School of Medicine, Boston, MA, USA.
- Center for Computational Biology and Bioinformatics, The Pennsylvania State University, University Park, PA, USA.
- Department of Biochemistry and Molecular Biology, The Pennsylvania State University, University Park, PA, USA.
MeSH
Hemoglobinopathies, Hematologic Diseases, Therapeutics